Amicus Therapeutics Inc (FOLD) Form 4 Filed by Daphne Quimi, Jan 06, 2023
SEC Form 4 · No Market Transaction
Tax Withholding
Shares withheld for tax obligations.
Equity Position
381K sh
385,080 → 381,196
Equity Change
-1.0%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Daphne Quimi CIK 0001543031 |
CFO
|
Daphne Quimi at Amicus Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Amicus Therapeutics Inc
| 2023-01-19 | Sell | -$152,444 | View |
| 2023-01-13 | Award | — | View |
| 2023-01-04 | Award | — | View |
| 2022-09-06 | Sell | -$49,621 | View |
| 2022-08-09 | Sell | -$69,576 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2023-01-04 | F - Tax Payment | 3,884 D | $12.03 | -$46,725 | 381,196 | Direct |
Related filings at Amicus Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
2
institutional managers reporting a position
Largest by reported value
- Ifp Advisors, Inc $11.5K
- Huntington National Bank $14
5%+ Holders · 13D/G
5 filers
-
Barclays Plc 5.7%
-
Ubs Group Ag 5.5%
-
Glazer Capital, Llc 0.0%
-
Black Rock, Inc. 7.4%
Other insiders at Amicus Therapeutics Inc
GET /v1/forms/4/0001209191-23-002400
API docs
View Original SEC Filing